Skip to content
Screener

Brady Corporation BRC Europe & Australia — R&D

Other segment segments

Americas & Asia
$16.95M+27.3%

Similar metrics at other companies

Aebi Schmidt Holding logo
AEBIEurope and ROW — R&D
$5.07M+25.9%
Insmed logo
INSMARIKAYCE external R&D expenses — R&D
$6.23M-43.4%
Insmed logo
INSMBrensocatib external R&D expenses — R&D
$13.83M-58.8%
Insmed logo
INSMTPIP external R&D expenses — R&D
$38.94M+88.6%
Insmed logo
INSMOther external R&D expenses — R&D
$48.84M+71.7%
Micron Technology logo
MUAEBU — R&D
$109M+0.9%

Other financials

Income statement

See full
Revenue$435.2M+13.8%
Gross profit$225.5M+15.6%
Operating income$73.2M+9.0%
Net income$57.8M+10.6%
EPS (diluted)$1.21+11.0%

Balance sheet

See full
Cash & equivalents$175.5M+15.3%
Total debt$88.5M-45.2%
Total equity$1.3B+15.1%
Total assets$1.8B+7.9%

Cash flow

See full
Operating cash flow$78.2M+30.7%
CapEx$11.0M+159%
Free cash flow$67.2M+20.8%

Valuation

See full
Market cap$4.63B+38.2%
Enterprise value$4.54B+36.3%
P/E22.1×+4.4×
P/S2.9×+0.6×

Profitability

See full
Gross margin51.1%+0.6pp
Operating margin16.2%-0.5pp
Net margin12.9%-0.4pp
FCF margin11.2%-1.0pp

Returns & leverage

See full
Return on equity16.7%-1.1pp
Debt / equity0.1×-0.1×
Current ratio2×+0.1×

Where this comes from

Reported directly by Brady Corporation in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The source filing: Brady Corporation’s 10-Q, filed May 18, 2026.

Filed
May 18, 2026, 7:06 AM EDT
Fiscal quarter
Q3 FY2026
Calendar quarter
Q2 2026
Accession
0000746598-26-000020
Line itemThree months ended April 30, 2026Three months ended April 30, 2025Nine months ended April 30, 2026Nine months ended April 30, 2025
Cost of goods sold69,98663,704200,487193,661
Gross margin75,19665,234213,622189,743
Segment expenses:
Research and development6,5775,87319,96417,390
Selling, general and administrative47,14941,883138,034130,481
Total segment expenses53,72647,756157,998147,871
Segment profit$21,470$17,478$55,624$41,872
Total profit from reportable segments$90,200$74,642$237,968$200,020

Item 1. Financial Statements (Unaudited)

FAQ

What is Brady Corporation's europe & australia — R&D?
Brady Corporation (BRC) reported europe & australia — R&D of $6.58M in Q1 2026.
How has Brady Corporation's europe & australia — R&D changed year-over-year?
Brady Corporation's europe & australia — R&D increased by 12.0% year-over-year, from $5.87M to $6.58M.
What is the long-term trend for Brady Corporation's europe & australia — R&D?
Over 2 years (2023 to 2025), Brady Corporation's europe & australia — R&D has grown at a 21.8% compound annual growth rate (CAGR), from $16.19M to $24.03M.
What does europe & australia — R&D mean?
Represents expenditures dedicated to the innovation, design, and improvement of identification and safety products within the Europe and Australia segment. It reflects the company's commitment to maintaining a competitive edge through technological advancement.

Ask your AI about Brady Corporation's europe & australia — r&d.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude